PT - JOURNAL ARTICLE AU - Diaz Perez, Kimberly K. AU - Chung, Sydney AU - Head, S. Taylor AU - Epstein, Michael P. AU - Hecht, Jacqueline T. AU - Wehby, George L. AU - Weinberg, Seth M. AU - Murray, Jeffrey C. AU - Marazita, Mary L. AU - Leslie, Elizabeth J. TI - Rare variants found in multiplex families with orofacial clefts: Does expanding the phenotype make a difference? AID - 10.1101/2023.02.01.23285340 DP - 2023 Jan 01 TA - medRxiv PG - 2023.02.01.23285340 4099 - http://medrxiv.org/content/early/2023/02/07/2023.02.01.23285340.short 4100 - http://medrxiv.org/content/early/2023/02/07/2023.02.01.23285340.full AB - Whole-exome sequencing (WES) is now a relatively straightforward process to identify causal variants in Mendelian disorders. However, the same is not true for WES in families where the inheritance patterns are less clear, and a complex etiology is suspected. Orofacial clefts (OFCs) are highly heritable birth defects with both Mendelian and complex etiologies. The phenotypic spectrum of OFCs may include overt clefts and several subclinical phenotypes, such as discontinuities in the orbicularis oris muscle (OOM) in the upper lip, velopharyngeal insufficiency (VPI), microform clefts or bifid uvulas. We hypothesize that expanding the OFC phenotype to include these phenotypes can clarify inheritance patterns in multiplex families, making them appear more Mendelian. We performed whole-exome sequencing to find rare, likely causal genetic variants in 31 multiplex OFC families, which included families with multiple individuals with OFCs and individuals with subclinical phenotypes. We identified likely causal variants in COL11A2, IRF6, KLF4, SHROOM3, SMC3, TP63, and TBX3 in seven families. Although we did not find clear evidence supporting the subclinical phenotype hypothesis, our findings support a role for rare variants in the etiology of OFCs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported with funding from the National Institutes of Health (X01-HG010012, T32-GM008490, R00-DE025060, R01-DE016148, R01-DE011931, R01-DE09886, R01-DE012472, P50-DE016215, R37-DE008559, R01-DE014667, R01-DD000295) and the Howard Hughes Medical Institute through the James H. Gilliam Fellowships for Advanced Study program. Sequencing services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268201700006I.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRBs of Emory University, the University of Pittsburgh, and local recruiting sites gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence and phenotype data is available from the Database of Genotypes and Phenotypes (dbGaP), study accession: phs001675.v1.p1.